OverviewChartNewsTraderScreen

Soc. Generale Knock-Out ZEG/  DE000SB95700  /

EUWAX
04/11/2024  08:45:58 Chg.0.00 Bid11:05:57 Ask11:05:57 Underlying Strike price Expiration date Option type
4.88EUR 0.00% 5.07
Bid Size: 10,000		 5.08
Ask Size: 10,000		 ASTRAZENECA PLC D... 69.0604 - 31/12/2078 Call
GlobeNewswire 12/08 Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire 08/08 Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire 06/08 Cellectis Provides Financial Results for the Second Quarter 2024
GlobeNewswire 06/08 FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update
TeleTrader 25/07 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 15/07 AstraZeneca Closes Acquisition of Amolyt Pharma
GlobeNewswire 26/06 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 18/06 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 13/06 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 28/05 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 21/05 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 20/05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 08/05 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 06/05 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 06/05 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 02/05 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 29/04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 28/03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 18/03 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 14/03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 14/03 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca